Colorcon Opens New Technical Services Lab in India

Article

The new technical services laboratory and conference facility in Noida, India will support continuing industry growth as well as provide local assistance to customers in the region.

Colorcon announced on June 2, 2017 that it has opened a new technical services laboratory and conference facility in Noida, India. The new laboratory, which is Colorcon’s 20th across the world, will support continuing industry growth as well as provide local assistance to customers in the region.

“The northern part of India is significant for Colorcon as it’s a pharmaceutical development and manufacturing hub,” Rajesh Parab, general manager of Colorcon South Asia, said in a press release. “This strategic investment demonstrates Colorcon’s commitment and focus to the fast-growing Indian pharmaceutical market in this region.”

According to Sailesh Verma, regional sales manager, the new laboratory will help customers respond to market dynamics and bring their products to market faster. Verma added that “this facility extends Colorcon’s direct support to customers and supplements the existing laboratory facilities established in Goa to provide a faster turnaround time for their projects and easy access to technical services.”

Customers will have the opportunity to conduct laboratory-scale coating trials at the new facility, using conventional and automated coating equipment that aligns with the equipment in their facilities; this approach could help save development and scale-up time.

The facility also provides the opportunity to extend the educational events offered through the Colorcon Academy, with resources to conduct Colorcon Coating Schools and Formulation Training Programs that will facilitate knowledge sharing and benefit individuals as well as their companies.

Source: Colorcon

 

Recent Videos
Behind the Headlines episode 6
CPHI Milan 2024: Highlighting the Benefits of Integrated Services
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content